Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

aTyr Pharma Inc (NASDAQ:LIFE)

3.05
Delayed Data
As of Dec 02
 -0.05 / -1.61%
Today’s Change
2.48
Today|||52-Week Range
10.93
-68.97%
Year-to-Date
No recent news for aTyr Pharma Inc.

Today’s Trading

Previous close3.10
Today’s open3.10
Day’s range2.90 - 3.10
Volume82,369
Average volume (3 months)175,907
Market cap$72.3M
Dividend yield--
Data as of 4:00pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)-185.71%
Earnings growth (this year)+17.93%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.63

Competitors

 Today’s
change
Today’s
% change
PPHMPeregrine Pharmaceut...+0.00+1.26%
SBPHSpring Bank Pharmace...-0.32-4.16%
ALIMAlimera Sciences Inc+0.01+0.94%
CAPRCapricor Therapeutic...+0.09+2.89%
Data as of 4:00pm ET, 12/02/2016

Financials

Next reporting dateApril 5, 2017
EPS forecast (this quarter)-$0.61
Annual revenue (last year)$0.00
Annual profit (last year)-$48.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman &
Chief Executive Officer
John D. Mendlein
Chief Medical Officer
Sanjay Shukla
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs